← FDA Drug Approvals (Drugs@FDA)
AKYNZEO
NDA · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2018-04-19
Drug application
- FDA Application #
NDA210493- Application type
- New Drug Application
- Brand name
- AKYNZEO
- Generic name
- FOSNETUPITANT AND PALONOSETRON
- Active ingredients
- FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- HELSINN HLTHCARE
- Manufacturer
- Helsinn Therapeutics (U.S.), Inc.
- First approval
- 2018-04-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown